Pharma Mar SA
MAD:PHM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharma Mar SA
MAD:PHM
|
ES |
|
Kelso Technologies Inc
TSX:KLS
|
CA |
|
Vir Biotechnology Inc
NASDAQ:VIR
|
US |
|
America Great Health
OTC:AAGH
|
US |
Wall Street
Price Targets
PHM Price Targets Summary
Pharma Mar SA
According to Wall Street analysts, the average 1-year price target for
PHM
is 99.09 EUR
with a low forecast of 64.99 EUR and a high forecast of 126 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PHM's stock price target?
Price Target
99.09
EUR
According to Wall Street analysts, the average 1-year price target for
PHM
is 99.09 EUR
with a low forecast of 64.99 EUR and a high forecast of 126 EUR.
What is Pharma Mar SA's Revenue forecast?
Projected CAGR
14%
For the last 14 years the
compound annual growth rate for
Pharma Mar SA's revenue is
2%.
The projected
CAGR
for the next 3 years is
14%.
What is Pharma Mar SA's Operating Income forecast?
Projected CAGR
42%
For the last 14 years the
compound annual growth rate for
Pharma Mar SA's operating income is
7%.
The projected
CAGR
for the next 3 years is
42%.
What is Pharma Mar SA's Net Income forecast?
Projected CAGR
26%
For the last 14 years the
compound annual growth rate for
Pharma Mar SA's net income is
22%.
The projected
CAGR
for the next 3 years is
26%.
